Skip to main content
PROFITVISIONLAB
Asset Allocation

The Year of the Active ETF: From Taiwan to US Stocks, Who's Actually Worth the Fee?

Taiwan's active ETFs delivered a stunning scorecard in 2025's 'Year One,' but a short track record and heavy holdings overlap are the caveats. This piece compares eight flagship US active ETFs — factor-based, options-income, and ARK's disruptive themes — and takes a hard look at whether the ARK family is really worth investing in.

Asset Allocation ProfitVision LAB | US Equity Options × Deep Stock Research × Practical AI Investing
The Year of the Active ETF: From Taiwan to US Stocks, Who's Actually Worth the Fee?
From Taiwan's active-ETF breakout in 2025 to the eight most-watched active ETFs in the US — same word "active," wildly different logic underneath
Core Thesis: An active ETF isn't automatically better than a passive one just because "someone is picking stocks for you." Taiwan's stock market did turn in an impressive scorecard in its 2025 "Year of the Active ETF," but the short track record and heavy concentration in AI components make that short-term performance hard to replicate. The US active-ETF ecosystem is far more mature — eight flagship names spanning factor investing, options-income strategies, and disruptive technology, each built on its own design logic. By the end of this piece, you should be able to answer one question: what exactly are you paying that management fee for?

Active vs. Passive: Clearing Up the Concept First

In the market, the three letters "ETF" describe a trading structure, not an investment strategy. Many people assume an ETF is inherently a passive index tracker, but that's simply the version that happened to become popular first, historically.

The real distinction is this:

📊 Passive ETFs

  • Track an index, mechanically replicate holdings
  • Goal: match the market's return
  • Low management fee (0.03%–0.2%)
  • Holdings transparent, adjusted per index rules
  • Suited to long-term core allocation
  • Examples: 0050, SPY, QQQ

🧠 Active ETFs

  • Fund manager actively decides holdings
  • Goal: beat the index (Alpha)
  • Higher management fee (0.5%–1%+)
  • Holdings disclosed daily (US requirement)
  • Suited to satellite allocation or thematic bets
  • Examples: ARKK, JEPQ, AVUV

The core selling point of an active ETF is "someone is actively managing this" — but that's a double-edged sword. Active management creates the possibility of alpha, but it also brings fee drag (Expense Drag) and the risk of human judgment error. Most academic research shows that over the long run, roughly 80% of active funds underperform their benchmark index. That number isn't meant to dismiss all active management — it's a reminder that choosing an active ETF means placing a bet that "this person / this system can beat the market."

📖 Why Is the Active ETF Such a New Thing in Taiwan?

Taiwan's ETF market opened as far back as 2003 and has now grown to over NT$6 trillion, ranking among the top three in Asia. But for most of that history, passive ETFs dominated the market — it wasn't until 2025, when the Financial Supervisory Commission allowed active ETFs to list, that the "year one" began. By comparison, the US active ETF market has been developing for two decades, pulling in nearly $475 billion in inflows in 2025 alone — a highly mature and fiercely competitive market.


Taiwan's Year One of Active ETFs: An Impressive Scorecard, With Caveats You Need to Know

In 2025, Taiwan's active ETFs put up genuinely striking performance — three of the top five performers on the board were active ETFs.

70.98%
Active Uni-President Taiwan Growth 00981A
Full-year 2025 return
54.44%
Active Nomura Taiwan Select 00980A
Full-year 2025 return
44.65%
Active Capital Taiwan Leaders 00982A
Full-year 2025 return

By comparison, the "national ETF" 0050 returned 36.87% for the year, ranking only tenth. That gap has prompted many investors to rethink the value of active management.

A Full Roundup of Taiwan's Active ETFs

TickerNameAUM (NT$100M)2025 ReturnStrategy Highlight
00981AActive Uni-President Taiwan Growth475+70.98%Heavy concentration in AI electronic components
00980AActive Nomura Taiwan Select~150+54.44%Large-cap blue chips + stock-selection model
00982AActive Capital Taiwan Leaders281+44.65%Fundamentals-based stock picking, mid-stream semiconductors
00990AActive Yuanta AI New Economy100+— (newly listed)AI theme, over NT$10B AUM right at launch
00991AActive Fuh Hwa Taiwan Future 50100+— (newly listed)Picks the top 50 future-technology names

Three Caveats You Need to Know

⚠️ Caveat One: The measurement period is incomplete. Most of Taiwan's active ETFs only listed between May and July of 2025 — 00981A's 70% return is measured from its May listing date, not a full calendar year. Entering the market in the tailwind of the second half is like starting the stopwatch only once the wind is already at your back.
⚠️ Caveat Two: Heavy concentration in the same AI holdings. The four major active ETFs share overlapping top holdings including TSMC, Auras, Wiwynn, Accton, Elite Material, and Delta Electronics. In substance, it's the same single bet: Taiwan's AI supply chain. Spreading capital across four active ETFs doesn't necessarily mean spreading risk.
⚠️ Caveat Three: They haven't been tested through a full business cycle. One year of bull-market performance isn't enough to judge whether a fund manager's stock-picking skill is real. That requires living through at least one significant drawdown before the true moat of active management can be seen.
"Active ETFs shine short-term, passive ETFs hold up long-term." — a common conclusion among market observers. This isn't a dismissal of active management — it's a reminder to place it in the right position within your portfolio.

US Active ETFs: Eight Curated Picks From a Mature Market

The US active-ETF ecosystem is far more complex than Taiwan's — systematic factor strategies (Dimensional, Avantis), options-income strategies (JPMorgan, NEOS), and disruptive technology (ARK) each serve different needs. In 2025, US active ETFs overall pulled in close to $475 billion in inflows, with the top six issuers — JP Morgan, Capital Group, Dimensional, iShares, American Century (Avantis), and Fidelity — together capturing roughly 50% of that flow.

The eight names below represent distinct strategic logics. Before picking one, ask yourself: are you after income, factor exposure, or a thematic bet?

Type One: Systematic Factor Investing (Factor-Based)

DFAC
Dimensional US Core Equity 2 ETF
AUM~$40.7B
Expense Ratio0.12%
Trailing 1-Year Return+19.06%
Systematically tilts toward small-cap, value, and profitability factors. Extremely low fee, consistently beating the large-blend category average. 3-year annualized 16.43%. One of the top picks for a long-term core holding.
AVUV
Avantis US Small Cap Value ETF
AUM~$13.0B
Expense Ratio0.25%
3-Year Category Rank4th percentile
Focuses on undervalued, highly-profitable companies within small caps. Morningstar ranks its 3-year return in the top 4% of its category. A precise tool for investors who favor small-cap value.
💡 What Is Factor Investing?

Factor investing means systematically tilting holdings toward characteristics that academic research has shown to produce long-term excess returns: the size effect, value, and profitability. Dimensional and Avantis are the most credible players in this space, led by former academic economists, with strategies that are repeatable and reasonably priced.

Type Two: Derivative Income

JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
AUM~$20.0B+
Expense Ratio0.35%
Morningstar Rating★★★★★
Distributions are largely taxed as ordinary income (not qualified dividends) — high-bracket investors should take note
Selects from the Nasdaq-100 and overlays a covered-call strategy, paying monthly with a high yield. Five-star Morningstar rating in the derivative-income category. Suits investors comfortable with tech-sector volatility who also want monthly cash flow.
SPYI
NEOS S&P 500 High Income ETF
AUM~$8.1B
Expense Ratio0.68%
3-Year Annualized Return15.9%
Annualized yield of roughly 12%, with a more tax-optimized structure than JEPQ
Holds S&P 500 constituents paired with a hybrid options strategy (selling calls + buying calls), delivering high income while retaining more upside participation. +18.4% in 2023, +19.0% in 2024, with after-tax returns close to pre-tax. Suits retirees or income investors who prioritize tax efficiency.
💡 An Options-Seller's View: JEPQ vs. SPYI

Both are essentially covered-call strategies packaged as ETFs — trading time value for fixed income, sacrificing some upside. JEPQ is a bet on Nasdaq tech volatility: when volatility is high, the option premium is richer. SPYI, through a more refined options structure, retains more upside participation while still generating high income, and most of its distributions are taxed as capital gains, giving it a meaningfully better tax profile than JEPQ. If you're holding in a taxable account, SPYI deserves priority consideration.

Type Three: The ARK Family — Actively Managed Disruptive Themes

ARK runs three funds spanning three themes: ARKK (broad disruptive tech), ARKX (aerospace and defense), and ARKG (genomics/biotech). In these three themes, the market has almost no other genuinely actively-managed ETF competitor — ITA, PPA, and SHLD (defense) and XBI, IBB, and BBH (biotech) are all passive index funds. ARK's scarcity is real; the question is whether scarcity is the same as worth owning.

ARKK
ARK Innovation ETF
AUM~$5.9B
Expense Ratio0.75%
2025 Return+35.6%
5-Year Total Return-42.67%
Broad disruption: AI, autonomous driving, crypto, genomics. +153% in 2020, -75% in 2022, a strong rebound in 2025. Top ten holdings account for 57.9%. 10-year annualized ≈14.65%, close to SPY — but with more than double SPY's volatility and a Sharpe Ratio well below the index.
ARKX
ARK Space & Defense Innovation ETF
AUM~$0.81B
Expense Ratio0.75%
2025 Return+49.2%
Comparable Active PeersAlmost none
Aerospace, space exploration, satellites, autonomous flight, cyber defense. Second-best performer in the ARK family in 2025. The only active aerospace/defense ETF of any real size — if you hold a thematic conviction here and trust ARK's stock selection, the scarcity has real meaning.
ARKG
ARK Genomic Revolution ETF
AUM~$1.0B
Expense Ratio0.75%
Annualized Since Inception~3.2% (since 2014)
10-Year Wealth Destruction$4.2B (Morningstar)
⚠️ Active biotech ETFs are scarce: XBI, IBB, and BBH are all passive index funds; ARKG is the only sizable active option — but that scarcity comes at a cost
Gene editing (CRISPR), genome sequencing (10x Genomics), AI-assisted drug discovery (Recursion, Tempus AI). 32 highly concentrated holdings. Twelve years since inception, with only a 3.2% annualized return — not even enough to clear the fee hurdle, making it the hardest fund in the ARK family to defend.
⚠️ The Core Problem Across the Whole ARK Family: Timing Risk Is Structural
Morningstar's data for 2014–2023 shows the entire ARK fund family was the single largest wealth destroyer in the US fund industry, costing investors a combined $14.3 billion — ARKK alone destroyed $7.1 billion and ARKG destroyed $4.2 billion. Large numbers of investors bought in at the 2020–2021 peak and exited after the 2022 crash, realizing actual returns far below the fund's reported time-weighted returns. ARK's boom-bust cyclical nature guarantees that most investors enter and exit at the wrong times. This isn't just a Cathie Wood problem — it's a trap created by the very structure of "thematic, high-volatility active ETFs."
🔬 Is the ARK Lineup Worth Investing In? Shiba the Disciplined's Take

ARKK: 10-year annualized return close to SPY, but with double the volatility and a 0.75% fee — on a risk-adjusted basis, not worth a core allocation, at most a speculative position of ≤5% with a firm stop-loss in place.

ARKX: Comparable active peers are almost nonexistent; if you hold a thematic conviction in aerospace and defense, a small position is acceptable. Continuing to outperform SPY into 2026 is a point in its favor.

ARKG: A 12-year annualized return of 3.2% can't be defended by "waiting for the breakout." Unless you have more than a decade of holding patience, passive alternatives like XBI or IBB offer a better edge on fees and diversification.

Type Four: International Small-Cap Value Factor

AVDV
Avantis International Small Cap Value ETF
AUM~$17.0B
Expense Ratio0.36%
InceptionSeptember 2019
AVUV's international counterpart — the same factor logic (small-cap + undervalued + profitable), applied to developed markets outside the US. Benchmarked against the MSCI World ex USA Small Cap Index, with a long track record of beating the benchmark. Holdings are spread across Japan, the UK, Europe, and Australia, making it an important diversification tool beyond USD assets.

Comparison Matrix of All Eight Picks: How Should You Choose?

ETFStrategy TypeExpense RatioVolatilitySuited ForCore Risk
DFACSystematic factor (US)0.12%MediumLong-term core allocationFactor premium fails long-term
AVUVUS small-cap value factor0.25%Medium-highSmall-cap exposure needsSmall caps lag large caps long-term
AVDVInternational small-cap value factor0.36%Medium-highDiversification outside USD + factor premiumUSD strength erodes returns
JEPQCovered call (Nasdaq)0.35%MediumTech exposure + monthly income needUpside capped when tech rallies sharply
SPYIHybrid options income0.68%Low-mediumTax efficiency + high yieldHigher fee, more complex strategy
ARKKBroad disruptive active0.75%Extremely highVery small speculative position (≤5%)-42% 5-year total return, extreme timing risk
ARKXAerospace/defense active0.75%HighInvestors with an aerospace/defense convictionNo comparable peer, cannot be benchmark-tested
ARKGGenomic revolution active0.75%Extremely highOnly for 10+ year super-long-term conviction holders12-year annualized only 3.2%, $4.2B in destroyed wealth

A Quick Decision Framework

Ask yourself three questions:

Question One: What's your purpose in buying an active ETF?
If it's "long-term wealth accumulation," factor funds (DFAC, AVUV, AVDV) have far more academic support than disruptive-growth bets. If it's "monthly cash flow," income funds (JEPQ, SPYI) fit the need. If it's a "thematic bet," ARKX (aerospace/defense) or ARKG (genomic revolution) each come with their own conviction prerequisites — but read their track records carefully first.

Question Two: How much of a drawdown can you stomach?
ARKK's peak-to-trough drawdown from 2021 to 2022 exceeded 75%, and ARKG's was roughly similar. If that number makes you uneasy, stay away from the entire ARK family. SPYI is designed with a downside-buffering mechanism and outperformed a plain long position during the 2022 bear market, but it still declines along with the market.

Question Three: How much fee are you willing to pay?
Every 0.1% difference in fees compounds into a substantial erosion of terminal value over 30 years. DFAC's 0.12% is nearly free, while the ARK lineup's 0.75% requires generating at least 0.6% of excess return every single year just to offset the fee drag. ARKG's historical annualized return of 3.2% doesn't even clear that bar.

✅ Shiba the Disciplined's Allocation Logic: Active ETFs are best suited as a satellite position — no single active ETF should exceed 20% of total portfolio weight. The core should remain low-fee index or factor funds, with the active sleeve used to express specific thematic views (aerospace/defense, small-cap value, income generation). If you do touch the ARK lineup, prioritize ARKX over ARKK, and ARKK over ARKG, and only enter at low points with a firm stop-loss set — echoing the core philosophy of an options-seller's strategy: bet where the odds favor you, don't chase in at emotional highs.

Taiwan Active ETFs vs. US Active ETFs: Structural Differences

DimensionTaiwan Active ETFsUS Active ETFs
Market maturity2025 is year one, just getting startedTwo decades of history, highly competitive
Holdings transparencyTop-10 holdings disclosed monthlyFull holdings disclosed daily (US requirement)
Strategy diversityCurrently nearly all Taiwan growth/AI themesDiverse: factor, income, thematic, fixed income
Fee levels~0.8%–1.2% (higher than passive)0.12%–0.75%, competition keeps fees down
Risk concentrationHeavy overlap in AI supply-chain holdingsWide strategy variation, more diversification choices
Short-term performanceRemarkable (within a specific bull-market window)Some names like ARK have a high-volatility track record
Fit for Taiwanese investorsA satellite position expressing a view on Taiwan's AI storyUSD-denominated core or thematic long-term positions

Conclusion: Is an Active ETF Worth It? Ask the Right Question First

The question about active ETFs was never "is someone picking stocks for me" — it's "can this person / this system keep generating returns above the fee, in whatever market environment comes next."

Taiwan's 2025 "year one" of active ETFs was genuinely a meaningful market evolution — it let more investors access something close to actively managed mutual-fund strategies with the transparency and liquidity of an ETF wrapper. But if your current mindset is "this one went up the most, I'll buy it," go back and reread the three caveats in section two.

The eight US names offer a more mature frame of reference: from a nearly-free systematic factor strategy (DFAC), to monthly-paying covered-call strategies (JEPQ/SPYI), to high-conviction tools for disruptive technology (the ARK lineup) — each one answers a specific question.

Think with me, not just trade with me. Before you pick an active ETF, first confirm which problem you're solving — not which ETF went up the most this year.

📋 Tracking Record

DateEventNotes
2026/04/24Initial publicationCovers a review of Taiwan's Year One of active ETFs + eight flagship US names + a full assessment of the ARK family
⚠️ This article is for research reference only and does not constitute investment advice. Investing involves risk; please evaluate carefully based on your personal financial situation. Data sources: Anue (CNYES), CMoney, Morningstar, ETF Trends, Kiplinger, public data.